Fig. 1 Representative pictures of Safranin-O stained frontal sections of paraffin embedded knee joints from Sham control operated mice and mice at 2, 4, 8 and 12 weeks post destabilisation of the medial meniscus (DMM) surgery. Cartilage of the medial tibia plateau (MTP) and femoral condyle (MFC) was evaluated for grades of cartilage destruction according to the OARSI guidelines. MM = medial meniscus. Asterisk (*) indicate discoloration due to proteoglycan loss, full arrows indicate osteophyte formation, arrow heads indicate irregular cartilage surface and open triangles indicate cartilage erosions down to the calcified cartilage zone.<\/figcaption><\/figure>\nMission and objectives<\/h3>\n
ExCarBon wants to dissect molecular pathways and cellular responses pivotal for articular cartilage and subchondral bone maintenance and destruction during OA. This can be done by using imaging and nanomechanical modalities to assess structure-to-function relationships. Inflammatory cell\u00ad\u00ad\u00ad responses in joint tissues and its relationship with onset and progression of OA need to be characterised. It is crucial to analyse the effect of mechanical stimuli and the physical microenvironment on cell-based regeneration processes.<\/p>\n
Our overall research concept connects cartilage\/synovial\/bone pathophysiology to regenerative osteo-chondrogenesis. We expect our integrated research activities to result in a comprehensive understanding of joint tissue pathophysiology and to identify and verify novel targets for diagnosis and therapeutic intervention in OA. This is expected to result in the development of novel strategies to halt OA progression and in improved therapies for the treatment of osteochondral lesions and synovial inflammation.<\/p>\n
During the previous work of ExCarBon, several aspects of OA pathology have yielded important insights into the progression of joint tissue degeneration in the frame of our clustered projects. Here, we further tailored our focus for the next years identifying six target areas, which require extensive collaboration and shared technologies among the consortium.<\/p>\n
The role of extracellular matrix and signalling in osteoarthritis<\/h3>\n
OA development is associated with a sequence of pathological changes of the articular cartilage extracellular matrix (ECM). We have shown that interfering with heparin sulphate biosynthesis or integrin-ECM interactions has a clear impact on the structure and\/or composition of the cartilage matrix, and on the organisation and function of the chondrocyte cytoskeleton. Our emerging concept shows those changes have a pivotal role in the initiation and onset of OA by altering \u00a0cartilage biomechanics and disrupting the ECM-cytoskeleton connection.<\/p>\n
Mechanotransduction in joint tissues<\/h3>\n
All types of cells in the joint are continuously exposed to mechanical forces, including external and reactive forces caused by the mechanical properties of the extracellular environment. Cells can sense and respond to mechanical forces, which play critical roles in various cellular activities, including motility, morphological changes, proliferation, differentiation and polarity formation as well as tissue morphogenesis, OA pathogenesis and AC repair.\u00a0 Previously we have revealed the importance of mechanotransduction in chondrocyte and mesenchymal stem cell (MSC) physiology as well as for subchondral bone microarchitecture.<\/p>\n
Calcified cartilage and bone changes in osteoarthritis<\/h3>\n
Alterations in calcified cartilage, subchondral bone, osteochondral junctions and other bony structures are frequently associated with OA pathogenesis. Histological and high-resolution nanoCT-aided analyses have demonstrated modification of the calcified tissues in almost all genetically modified, surgical OA and repair animal models of ExCarBon, further corroborating the importance of SB in OA pathogenesis. We will continue evaluating structural and molecular changes in bone and its mutual interaction with cartilage biomechanics in the next years.<\/p>\n
Peripheral nervous system in OA and repair<\/h3>\n
We have previously shown that changes in sensory and sympathetic neurotransmitter profiles and the absence of their neurotransmitters contribute to degenerative alterations in joint tissues and alter MSC-mediated repair processes in vitro. We will further study the role of the peripheral nervous system in OA pathophysiology using mechanical instability models, animal models under different stress conditions and will correlate the sympathetic tone with OA symptoms in human patients.<\/p>\n